Report
Pierre Tegner

L'Oreal : H1 EPS expected to be up +9.5% with organic growth of +7.4%

>Neutral recommendation maintained - The share's good performance in 2018 has not been an obstacle at all in 2019 (+24% YTD). Against the backdrop of low rates that are favourable to consumer staples stocks, L’Oréal is continuing to win over investors keen on capitalising on the popularity of luxury stocks via a vehicle that is more defensive than investments in pure players. L’Oréal probably stands to gain from a change in the valuation hierarchy of consumer sta...
Underlying
L'Oreal SA

L'Oreal acts as a holding company. Through its subsidiaries, Co. plays a strategic coordination role and scientific, industrial and marketing coordination role on a global basis. Co. develops, manufactures and commercializes products for Skin care, Hair care, Make-up, Perfumes, Toiletries and deodorants, and Oral cosmetics. Co. has three branches: Cosmetics, Body shop and Dermatology. Co.'s principal activities comprise four divisions: Professional Products, Consumer Products, L'Oreal Luxe and Active Cosmetics. The Body Shop branch offers various cosmetics and toiletry products. The Dermatology branch offers topical dermatology prescription, and corrective and aesthetic dermatology.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Pierre Tegner

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch